Patients with dominant negative variants in RELA have additional inflammatory presentations compared with RELA haploinsufficiency, including IBD, JIA, and skin manifestations, resembling type 1 interferonopathies (153). This evidence concerns the gene RELA and type 1 interferonopathy.